Search for: "PAR PHARMACEUTICALS"
Results 241 - 260
of 303
Sort by Relevance
|
Sort by Date
8 May 2009, 8:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Mircera (Methoxy polyethylene glycol-epoetin beta) – US: Federal Circuit revises Amgen v ITC (Patently-O) (Patent Baristas) (ITC 337 Law Blog) (Hal Wegner) (Patent Docs) General Alicia Greenidge to step down as Director of IFPMA (Intellectual Property Watch) Flu crisis could lead to compulsory licences (Managing… [read post]
29 Apr 2009, 11:47 am
Meanwhile, Vice President Joe Biden says Obama is searching for the nation’s first copyright czar, a cabinet-level position created by Congress to be on par with the drug czar. [read post]
23 Apr 2009, 10:00 pm
(Spicy IP) India: Assessing India’s innovation climate (Biotech Blog) Kenya’s anti-counterfeit legislation, India protest (Afro-IP) Mexico: Pharmaceutical trade marks: the Health Law pitfall for applicants (International Law Office) US: BIO IP Counsels’ Committee: Q Todd Dickinson and E Anthony Figg on patent reform (Patent Docs) US: Amgen VP makes case for longer exclusivity period in follow-on biologics legislation (Patent Docs) Products Cepham… [read post]
22 Apr 2009, 6:14 am
., a specialty pharmaceutical company, reported Christine Caufield in an April 17, 2009 article posted on Law360.com. [read post]
19 Apr 2009, 7:13 pm
Par Pharmaceutical, Inc. v. [read post]
13 Apr 2009, 5:00 am
Reddy’s and it’s negotiations with health insurers to sell its Simvastatin (Zocor) on par with the generic. [read post]
9 Apr 2009, 7:52 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US CAFC clarifies obviousness standard in context of cDNA cloning invention: In re Kubin (Holman's Biotech IP Blog) (Patent Docs) (Hal Wegner) (Philip Brooks' Patent Infringement Updates) (Patently-O) (Patent Docs) Xigris (Drotrecogin alfa) –US: CAFC: Pioneering claims require more expansive written description: Ariad v Eli… [read post]
6 Apr 2009, 11:19 am
The Challenges and Opportunities in India The challenge now is to develop biogenerics at par with chemical counterparts. [read post]
1 Apr 2009, 2:07 am
In the settlement, UBS agreed to buy the securities back from retail investors at par value, or to make up the difference to retail investors who had already sold for less than par. [read post]
27 Mar 2009, 8:00 am
(Intellectual Property Watch) Two final thoughts on big pharma acquisitions (IP finance) Brazil: Patent term cutbacks in Brazil and pharmaceutical pipelines – IP Think Tank podcast 23 March 2009 (IP Think Tank) Brazil: Patent term cutbacks - Lobbying, intellectual property and superior courts (IP Think Tank) Brazil: Patent term extension (PTE) under TRIPs revisited and reviewed by Superior Court of Justice (IP tango) Denmark: Harmonisation in Denmark: Patents covering… [read post]
20 Mar 2009, 2:05 am
Ill. 1987).Indiana: Ortho Pharmaceutical Corporation v. [read post]
9 Mar 2009, 7:00 am
Skylight Studios275 Hudson Street, NYC7 pm - 10 pmPURCHASE TICKETS Participating chefs Anne BurrellThe Food Network Anita LoAnnisa Pichet OngP*ONG Suvir SaranDevi Lawrence Benenson Fiona and Stanley Druckenmiller Leslie Fay Pomerantz Anita Jaffe Bloomberg Davis Polk & Wardwell Jeffrey FashionCares 2009 May and Samuel Rudin Family Foundation Sonnenschein Nath &… [read post]
FTC and California AG Join in Challenging Reverse Payment Settlements in the Pharmaceutical Industry
6 Mar 2009, 7:03 am
The complaint also names generic pharmaceutical companies Watson Pharmaceuticals, Par Pharmaceuticals and Paddock Laboratories. [read post]
2 Mar 2009, 1:47 am
Hat tip to the Courthouse News Service for the KV Pharmaceutical complaint. [read post]
27 Feb 2009, 5:00 am
USA, Inc (Orange Book Blog) (FDA Law Blog) (Patent Baristas) (Law360) (Patent Docs) (Patent Prospector) (Patently-O) (GenericsWeb) (Hal Wegner) Famvir (Famciclovir) – US: Teva loses bid to toss Novartis wilful infringement claims over Famvir (Law360) Fentora (Fentanyl) – US: Barr alleges Cima and Cephalon’s patent suit just a delay tactic (Law360) Integrilin (Eptifibatide) – US: Schering alleges patent infringement following Teva’s Para IV… [read post]
13 Feb 2009, 5:00 am
(PharmaLittle) US: PerkinElmer sues Interna to invalidate down syndrome test patent (Law360) US: Monsanto files patent suit against Michigan farmers Earl and Richard Schroeder accusing them of planting pesticide-resistant seeds without paying proper royalties (Law360) US: Case to watch: preclusive effect of prior claim construction: Shire v Sandoz (Patently-O) Products AndroGel (Testosterone) - US: Federal Trade Commission continues campaign against reverse payments, filing complaint… [read post]
6 Feb 2009, 5:00 am
(IP finance) Pharmaceutical Technology article on barriers to entry for generic pharma companies based in emerging economies (Afro-IP) The effects of IP protection on agricultural research: Patents are not the problem – response to Nature Biotechnology article ‘Patents Versus Patenting: Implications of Intellectual Property Protection for Biological Research’ (Patent Docs) SPC seminar – a brief report (The SPC Blog) (The SPC Blog) Ruminations on the… [read post]
3 Feb 2009, 2:55 pm
The Federal Trade Commission has filed a complaint in federal district court challenging agreements by Solvay Pharmaceuticals, which paid generic drug makers Watson Pharmaceuticals and Par Pharmaceutical Companies to delay launching generic versions of Solvay's brand name testosterone-replacement drug AndroGel, a prescription pharmaceutical with annual sales of more than $400 million. [read post]
22 Jan 2009, 2:06 am
As we reported yesterday, the California Supreme Court denied the petitions for review in Wyeth v. [read post]
15 Jan 2009, 8:00 am
A number of companies have also agreed to an Advisory Vote, including Verizon, MBIA, H&R Block, Blockbuster, Par Pharmaceuticals and Tech Data. [read post]
